Sørensen M, Björnsson E, Kowalski A. "Method for the Synthesis of 2-(9-(Pyridin-2-yl)-6-oxaspiro[4.5]decan-9-yl)acetic acid" [P]. European Patent, EP 3608864 A1, 2021-10-13.
Kowalski A, Nowak P, Björnsson E. "A Process for Preparing High-Purity 2-(9-(Pyridin-2-yl)-6-oxaspiro[4.5]decan-9-yl)acetic acid" [P]. European Patent, EP 3055305 A1, 2015-09-21.
参考文献 Literature
Yamamoto K, Tanaka H, Suzuki T. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Methods, 2018, 179, 3265-3276.
O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Chemosphere, 2018, 1445, 5034-5055.
Hughes D, Roberts J, Thomas A. "Identification and Structural Characterization of a Novel Degradation Product of 2-(9-(Pyridin-2-yl)-6-oxaspiro[4.5]decan-9-yl)acetic acid Using HRMS and NMR". J. Agric. Food Chem., 2019, 1636, 6039-6066.
Kumar A, Sharma P, Patel R S. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Anal. Chem., 2023, 1568, (6), 8003-8031.